Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01020
Species: Homo sapiens
Position : chr8:129188417-129189959
Year: 2016
Title: Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  26656844
MONDO: MONDO:0005061
Tissue: lymph node
Tissue Ontology ID: UBERON:0000029
Cell Source: NCI-H2009
CVCL ID: CVCL_1514
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Functional perturbation assay; Enhancer activity assay; Chromatin profiling; Endogenous enhancer perturbation
High Throughput Method: H3K27ac ChIP-seq; p300 ChIP-seq; DNase-seq; RNA-seq; copy-number analysis
Low Throughput Method: Luciferase reporter assay; KRAB-dCas9 CRISPRi; CRISPR/Cas9 enhancer deletion; RT-qPCR; deletion PCR and Sanger sequencing; anchorage-independent growth assay; clonogenic assay; CRISPR-Cas9 endogenous deletion/editing
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 9 found
Enhancer ID Position Tissue Cell Disease
E_00951 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_00974 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_00975 chr8:129166547-129190290 lung malignant cell lung adenocarcinoma
E_02502 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_02503 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_02504 chr8:129180000-129190000 lymph node B cell diffuse large B-cell lymphoma
E_00949 chr8:129188417-129189959 lung malignant cell lung adenocarcinoma
E_00950 chr8:129188417-129189959 lung malignant cell lung adenocarcinoma
E_01025 chr8:129188417-129189959 lung club cell lung adenocarcinoma
Expression of Target Genes for the Enhancer